These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 1173491)

  • 1. Effect of post-ovulatory administered oestrogens on corpus luteum function.
    Lehmann F; Just-Nastansky I; Behrendt B; Czygan PJ; Bettendorf G
    Acta Endocrinol (Copenh); 1975 Jun; 79(2):329-36. PubMed ID: 1173491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of 17alpha-ethinyl-19-nortestosterone (ENT) on corpus luteum function.
    Lehmann F; Just-Nastansky I; Czygan PJ; Bettendorf G
    Eur J Obstet Gynecol Reprod Biol; 1976; 6(4):219-22. PubMed ID: 987942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Simultaneous study of plasma gonadotropins, estrogens, progesterone and 17-hydroxyprogesterone during the ovulatory cycle].
    Roger M; Veinante A; Soldat MC; Tardy J; Tribondeau E; Scholler R
    Nouv Presse Med; 1975 Sep; 4(30):2173-8. PubMed ID: 1178478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Follicular fluid treatment during the follicular versus luteal phase of the menstrual cycle: effects on corpus luteum function.
    Stouffer RL; Hodgen GD; Ottobre AC; Christian CD
    J Clin Endocrinol Metab; 1984 Jun; 58(6):1027-33. PubMed ID: 6427256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent versus transient stimulation of the macaque corpus luteum during prolonged exposure to human chorionic gonadotropin: a function of age of the corpus luteum.
    Ottobre JS; Stouffer RL
    Endocrinology; 1984 Jun; 114(6):2175-82. PubMed ID: 6723578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of folliculogenesis and ovulation by the antiprogesterone RU 486.
    Luukkainen T; Heikinheimo O; Haukkamaa M; Lähteenmäki P
    Fertil Steril; 1988 Jun; 49(6):961-3. PubMed ID: 3371492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mid-cycle contraception with LHRH in women.
    Maia H; Barbosa IC; Maia H; Coutinho EM
    Reproduccion; 1981; 5(4):251-60. PubMed ID: 7033017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of short-term cyclic administration of cyproterone acetate on pituitary-ovarian function in the human.
    Kumari GI; Das RP; Madoiya KK; Jain AK; Roy S
    Fertil Steril; 1977 Nov; 28(11):1168-74. PubMed ID: 562781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The sequence of pituitary responses to synthetic luteinizing hormone releasing hormone (LH-RH) throughout the normal menstrual cycle.
    Grimes EM; Thompson IE; Taymor ML
    Acta Endocrinol (Copenh); 1975 Aug; 79(4):625-34. PubMed ID: 1098349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma levels of progesterone during the luteal phase in normal women treated with synthetic oestrogens (RS 2874, F 6103 and ethinyloestradiol).
    Johansson ED; Gemzell C
    Acta Endocrinol (Copenh); 1971 Nov; 68(3):551-60. PubMed ID: 5171371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of postovulatory treatment with a luteinizing hormone-releasing hormone analog on the plasma level of progesterone in women.
    Koyama T; Ohkura T; Kumasaka T; Saito M
    Fertil Steril; 1978 Nov; 30(5):549-52. PubMed ID: 363461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local changes in blood flow within the preovulatory follicle wall and early corpus luteum in cows.
    Acosta TJ; Hayashi KG; Ohtani M; Miyamoto A
    Reproduction; 2003 May; 125(5):759-67. PubMed ID: 12713439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of luteal function by a luteinizing hormone-releasing hormone antagonist during the early luteal phase in the stumptailed macaque monkey and the effects of subsequent administration of human chorionic gonadotropin.
    Fraser HM; Nestor JJ; Vickery BH
    Endocrinology; 1987 Aug; 121(2):612-8. PubMed ID: 3109885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation.
    Croxatto HB; Salvatierra AM; Romero C; Spitz IM
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1272-7. PubMed ID: 3119656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Plasma concentrations of LH and of sex steroids during the normal menstrual cycle and during contraceptive treatment].
    Bayard F; Louvet JP; Moatti JP; Smilovici W; Duguet L; Boulard C
    J Gynecol Obstet Biol Reprod (Paris); 1975; 4(7):915-26. PubMed ID: 767402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma steroid and luteinizing hormone levels during prostaglandin F 2 administration in luteal phase of menstrual cycle.
    Hillier K; Dutton A; Corker CS; Singer A; Embrey MP
    Br Med J; 1972 Nov; 4(5836):333-6. PubMed ID: 4637514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Onapristone (ZK 98.299): a potential antiprogestin for endometrial contraception.
    Katkam RR; Gopalkrishnan K; Chwalisz K; Schillinger E; Puri CP
    Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 1):779-87. PubMed ID: 7573244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of folliculogenesis in the monkey following early follicular phase administration of an LRH agonist.
    Wilks JW
    Acta Endocrinol (Copenh); 1984 Aug; 106(4):538-43. PubMed ID: 6433613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of RU486 administered during the proliferative and secretory phase of the cycle on the bleeding pattern, hormonal parameters and the endometrium.
    Swahn ML; Johannisson E; Daniore V; de la Torre B; Bygdeman M
    Hum Reprod; 1988 Oct; 3(7):915-21. PubMed ID: 2846630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The rhesus monkey corpus luteum is dependent on pituitary gonadotropin secretion throughout the luteal phase of the menstrual cycle.
    Hutchison JS; Zeleznik AJ
    Endocrinology; 1984 Nov; 115(5):1780-6. PubMed ID: 6436009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.